Ohtuvayre

Active Ingredient(s): Ensifentrine
FDA Approved: * June 26, 2024
Pharm Company: * VERONA PHARMA
Category: Lungs (Pulmonary)
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Ohtuvayre 3 mg/2.5ml Respiratory (Inhalation) Suspension
NDC: 83034-003
Labeler:
Verona Pharma, Inc.